Atlas Trials

Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients

Clinical trial NCT04998864 · COMPLETED

Trial details

NCT number
NCT04998864
Sponsor
InSightec
Status
COMPLETED
Study type
OBSERVATIONAL
Glioma, MalignantGlioblastoma
Start date
2021-08-25
Primary completion
2023-07-27
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.